Skip to main navigation Skip to search Skip to main content

NIVO-ALCL - Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma

Project Details

Short titleNIVO-ALCL - Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma
StatusActive
Effective start/end date1/09/19 → 31/08/27

Funding

  • Children's Cancer And Leukaemia Group
  • Institut De Cancerologie Gustave Roussy